This article is more than 5 years old. Information may no longer be current.
ACC, STS Launch US TAVR Registry
Click Here to Manage Email Alerts
The American College of Cardiology and Society of Thoracic Surgeons have launched a registry designed to monitor real-world outcomes of transcatheter aortic valve replacement in the United States.
According to a press release, the TVT Registry is a first-of-its-kind registry that will monitor the safety and efficacy of TAVR and will be positioned to incorporate additional catheter-based procedures that are not marketed in the United States. The registry will also be linked to the Social Security Death Master File and CMS databases to track long-term outcomes.
“The TVT Registry will provide an ideal mechanism for monitoring the use of transcatheter valve therapy,” David R. Holmes Jr., MD, president of the ACC, said in the press release. “The registry can provide relatively rapid feedback to individual sites and help identify trends in its usage. The registry will also provide a rich source of data for long-term research.”
Michael J. Mack, MD, president of the Society of Thoracic Surgeons (STS), also commented in the release, saying the standardized, evidence-based data source “will offer much insight into clinical practice patterns and patient outcomes. I believe this coordinated effort optimizes patient safety and ensures the appropriate use of TAVR therapy.”
To facilitate accurate and reliable data collection, the ACC and STS will sponsor educational opportunities and events for data managers, such as webinars and conference calls. Participating hospitals will also receive quarterly reports comparing an institution’s procedure performance with that of the national experience. In addition, the registry measures will also look at patient risk factors to adjust for case-mix and adverse event rates.